Blog
Slideshow
Author(s):
An action plan for physicians to protect themselves against malpractice litigation related to medications like Ozempic.
As a specialized medical malpractice broker, I am focused on protecting my physician and surgeon clients from the imminent surge of weight loss drug-related malpractice claims. In this article, we give five tips for physicians to protect themselves from claims related to glucagon-like peptide-1 (GLP-1) medications like Ozempic.
Max Schloemann is the founder of MEDPLI Professional Liability Insurance
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.